MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Total Current Liabilities (2015 - 2026)

MetaVia's (MTVA) quarterly Total Current Liabilities came in at $5.6 million in Q4 2025, down 31.71% YoY from $8.3 million in Q4 2024, and down 33.03% on a QoQ basis from $8.4 million in Q3 2025.

MetaVia (MTVA) Total Current Liabilities (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Total Current Liabilities data on file, last reported at $5.6 million in Q4 2025.

  • Quarterly Total Current Liabilities fell 31.71% year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (down 31.71% YoY) and the FY2025 annual result came in at $5.6 million, down 31.71% from the prior year.
  • Total Current Liabilities eased to $5.6 million in Q4 2025, from $8.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $11.8 million in Q4 2022 to a low of $944000.0 in Q1 2021.
  • A 5-year average of $5.6 million and a median of $5.8 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities plunged 74.53% — and 2023, when it surged 633.96%.
  • Tracing MTVA's Total Current Liabilities over 5 years: stood at $2.2 million in 2021, then surged by 446.31% to $11.8 million in 2022, then slumped by 49.42% to $6.0 million in 2023, then surged by 38.78% to $8.3 million in 2024, then tumbled by 31.71% to $5.6 million in 2025.
  • The last three Total Current Liabilities figures came in at $5.6 million (Q4 2025), $8.4 million (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 630.93 Mn
10 MetaVia 8.72 Mn -3.92 Mn - 6.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.35 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 8.43 Mn
Jun 30, 2025 8.82 Mn
Mar 31, 2025 7.71 Mn
Dec 31, 2024 8.27 Mn
Sep 30, 2024 9.11 Mn
Jun 30, 2024 9.71 Mn
Mar 31, 2024 6.83 Mn
Dec 31, 2023 5.96 Mn
Sep 30, 2023 4.72 Mn
Jun 30, 2023 3.98 Mn
Mar 31, 2023 10.98 Mn
Dec 31, 2022 11.78 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 1.25 Mn
Mar 31, 2022 1.50 Mn
Dec 31, 2021 2.16 Mn
Sep 30, 2021 1.90 Mn
Jun 30, 2021 1.18 Mn